This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland

Dr. Kaare Bjerregaard-Andersen, PhD
Principal Scientist at Lundbeck
Speaker

Profile

Kaare Bjerregaard-Andersen is a Principal Scientist at Lundbeck. He holds a Ph.D. degree from the University of Oslo, Norway, where he did his research within the fields of structural biology and biophysics. Currently, at Lundbeck, he serves as a research project leader, tasked with delivering new therapeutics to address unmet medical needs. In addition to this lead role, he has a strong focus on downstream processes, antibody engineering, and developability.

Agenda Sessions

  • Optimizing Antibody Functionality and Developability Through Machine Learning-guided Engineering

    11:50